402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: Results of a phase 1 dose-escalation study
    Journal Article

    Reece, D. E.; Sanchorawala, V.; Hegenbart, U.; Merlini, G.; Palladini, G.; Fermand, J. P.; Vescio, R. A.; Liu, X.; Elsayed, Y. A.; Cakana, A.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Issues in long-term opioid therapy: Unmet needs, risks, and solutions
    Journal Article

    Passik, S. D.
    Mayo Clinic Proceedings (2009)

    Fulltext@MSK | Save
  • Propofol infusion syndrome: Case report and literature review
    Journal Article

    Orsini, J.; Nadkarni, A.; Chen, J.; Cohen, N.
    American Journal of Health-System Pharmacy (2009)

    Fulltext@MSK | Save
  • Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial
    Journal Article

    O'Connor, O. A.; Moskowitz, C.; Portlock, C.; Hamlin, P.; Straus, D.; Dumitrescu, O.; Sarasohn, D.; Gonen, M.; Butos, J.; Neylon, E.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • A Population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-hodgkin's or hodgkin's lymphoma
    Journal Article

    Mould, D. R.; Sweeney, K.; Duffull, S. B.; Neylon, E.; Hamlin, P.; Horwitz, S.; Sirotnak, F.; Fleisher, M.; Saunders, M. E.; O'Connor, O. A.
    Clinical Pharmacology & Therapeutics (2009)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225
    Journal Article

    Lee, N.; Harris, J.; Garden, A. S.; Straube, W.; Glisson, B.; Xia, P.; Bosch, W.; Morrison, W. H.; Quivey, J.; Thorstad, W.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Pentostatin treatment combinations in chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kay, N. E.
    Clinical Advances in Hematology & Oncology (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Yataghene, K.; Jhanwar, S. C.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2009)

    Fulltext@MSK | Save
  • Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors
    Journal Article

    Ku, G. Y.; O'Reilly, E. M.; Saltz, L. B.; Schrag, D.; Maki, R. G.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2009)

    Fulltext@MSK | Save